Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy Adults

12 novembre 2026 aggiornato da: Driscoll's

This is a decentralized, single-arm, within-subject crossover clinical study evaluating the effects of Driscoll's Raspberries and Driscoll's Blackberries on postprandial glycemic response, satiety, and consumer appeal in healthy adults aged 18-65 years. Forty participants will each consume three standardized breakfast meals - a raspberry-inclusive meal, a blackberry-inclusive meal, and a sugar-reference meal - in any order over a two-week period, wearing a continuous glucose monitor (CGM) throughout.

All study activities are conducted remotely at participants' homes. CGM data will be used to compute incremental area under the glucose-time curve (iAUC) over the two-hour postprandial window following each meal. Self-reported questionnaires will assess satiety, energy, digestive comfort, and sensory appeal following each meal condition.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

40

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Nevada
      • Las Vegas, Nevada, Stati Uniti, 89101
        • Citruslabs

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 65 anni (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Be male or female.
  • Adult aged 18-65 years.
  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
  • Willing and able to wear a CGM device continuously for the two-week study period.
  • Willing to consume three standardized breakfast meals over the two-week study period, each consumed after an overnight fast of at least eight hours, with a minimum of 24 hours between each standardized meal event.
  • Willing to purchase and eat fresh Driscoll's Raspberries and Driscoll's Blackberries from a local retailer using a sponsor-provided berry stipend for use in the standardized meals.
  • Have reasonable access to a retailer that sells Driscoll's-branded raspberries and blackberries.
  • Have access to a smartphone or computer with a reliable internet connection.
  • Willing to maintain the same diet and exercise regimen consistently throughout the study duration.
  • Willing and able to complete all required digital surveys via the Citruslabs study platform at Baseline, and at the end of the day following Meal 1, Meal 2, and Meal 3.
  • Resides in the United States.

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
  • Anyone currently undergoing treatment for cancer, or have had a serious illness requiring hospitalization in the last 3 months.
  • Known or suspected allergy or hypersensitivity to raspberries, blackberries, or other berry species.
  • Known or suspected allergy, intolerance, or sensitivity to oats or gluten that would prevent consumption of the standardized oat-based meal component.
  • Current diagnosis of type 1 diabetes, type 2 diabetes, or prediabetes.
  • Current use of any medications or supplements known to significantly affect blood glucose levels, including but not limited to: insulin, metformin, GLP-1 receptor agonists, SGLT-2 inhibitors, sulfonylureas, or other glucose-lowering agents.
  • Known skin sensitivity to adhesives or prior documented adverse reaction to CGM sensors or similar transcutaneous monitoring devices.
  • Presence of implanted electronic devices (e.g., pacemaker, implantable cardioverter-defibrillator) that may be contraindicated with CGM device use, per the CGM manufacturer's specifications.
  • Pregnant, breastfeeding, or planning to become pregnant during the study period.
  • Anyone with a history of substance abuse.
  • Anyone who is currently a smoker or has been a smoker in the past three months.
  • Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.
  • History of an eating disorder currently requiring active clinical treatment.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Driscoll's Blackberries Arm

All participants complete all three meal conditions in any sequence.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Incremental Area Under the Glucose-Time Curve (iAUC) - Raspberry Meal vs. Sugar-Reference Meal
Lasso di tempo: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of raspberry meal vs. sugar-reference meal

Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
Incremental Area Under the Glucose-Time Curve (iAUC) - Blackberry Meal vs. Sugar-Reference Meal
Lasso di tempo: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of blackberry meal vs. sugar-reference meal

Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Self-Reported Hunger
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Fullness
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Desire to Eat
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Energy Levels
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Digestive Comfort
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Bloating
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Perceived Sweetness of Meal
Lasso di tempo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Palatability of Meal
Lasso di tempo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Motivation to Eat Healthier the Rest of the Day
Lasso di tempo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Overall Acceptability of Meal
Lasso di tempo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 novembre 2026

Completamento primario (Stimato)

1 dicembre 2026

Completamento dello studio (Stimato)

1 dicembre 2026

Date di iscrizione allo studio

Primo inviato

12 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

12 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

12 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • DRISC-40019

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi